Dysregulation of mitochondrial dynamics proteins are a targetable feature of human tumors
Anderson, Gray R., Wardell, Suzanne E., Cakir, Merve, Yip, Catherine, Ahn, Yeong-ran, Ali, Moiez, Yllanes, Alexander P., Chao, Christina A., McDonnell, Donald P., Wood, Kris C.
Published in Nature communications (26.04.2018)
Published in Nature communications (26.04.2018)
Get full text
Journal Article
CDK4/6 Therapeutic Intervention and Viable Alternative to Taxanes in CRPC
Stice, James P, Wardell, Suzanne E, Norris, John D, Yllanes, Alexander P, Alley, Holly M, Haney, Victoria O, White, Hannah S, Safi, Rachid, Winter, Peter S, Cocce, Kimberly J, Kishton, Rigel J, Lawrence, Scott A, Strum, Jay C, McDonnell, Donald P
Published in Molecular cancer research (01.06.2017)
Published in Molecular cancer research (01.06.2017)
Get full text
Journal Article
Pharmacokinetic and pharmacodynamic analysis of fulvestrant in preclinical models of breast cancer to assess the importance of its estrogen receptor-α degrader activity in antitumor efficacy
Wardell, Suzanne E., Yllanes, Alexander P., Chao, Christina A., Bae, Yeeun, Andreano, Kaitlyn J., Desautels, Taylor K., Heetderks, Kendall A., Blitzer, Jeremy T., Norris, John D., McDonnell, Donald P.
Published in Breast cancer research and treatment (01.01.2020)
Published in Breast cancer research and treatment (01.01.2020)
Get full text
Journal Article
Correction to: Pharmacokinetic and pharmacodynamic analysis of fulvestrant in preclinical models of breast cancer to assess the importance of its estrogen receptor-α degrader activity in antitumor efficacy
Wardell, Suzanne E., Yllanes, Alexander P., Chao, Christina A., Bae, Yeeun, Andreano, Kaitlyn J., Desautels, Taylor K., Heetderks, Kendall A., Blitzer, Jeremy T., Norris, John D., McDonnell, Donald P.
Published in Breast cancer research and treatment (01.02.2020)
Published in Breast cancer research and treatment (01.02.2020)
Get full text
Journal Article
Correction to: Pharmacokinetic and pharmacodynamic analysis of fulvestrant in preclinical models of breast cancer to assess the importance of its estrogen receptor-[alpha] degrader activity in antitumor efficacy
Wardell, Suzanne E, Yllanes, Alexander P, Chao, Christina A, Bae, Yeeun, Andreano, Kaitlyn J, Desautels, Taylor K, Heetderks, Kendall A
Published in Breast cancer research and treatment (01.02.2020)
Published in Breast cancer research and treatment (01.02.2020)
Get full text
Journal Article
Pharmacokinetic and pharmacodynamic analysis of fulvestrant in preclinical models of breast cancer to assess the importance of its estrogen receptor-[alpha] degrader activity in antitumor efficacy
Wardell, Suzanne E, Yllanes, Alexander P, Chao, Christina A, Bae, Yeeun, Andreano, Kaitlyn J, Desautels, Taylor K, Heetderks, Kendall A
Published in Breast cancer research and treatment (01.01.2020)
Published in Breast cancer research and treatment (01.01.2020)
Get full text
Journal Article
Abstract 5641: Effects of G1T48, a novel orally bioavailable selective estrogen receptor degrader (SERD), and the CDK4/6 inhibitor, G1T38, on tumor growth in animal models of endocrine resistant breast cancer
Wardell, Suzanne E., Yllanes, Alexander P., Baker, Jennifer G., Baldi, Robert M., Krebs, Taylor K., Sorrentino, Jessica, Bisi, John, Strum, Jay, Norris, John D.
Published in Cancer research (Chicago, Ill.) (01.07.2017)
Published in Cancer research (Chicago, Ill.) (01.07.2017)
Get full text
Journal Article
Abstract 1588: Effects of the selective CYP17-lyase and androgen receptor (AR) inhibitor, seviteronel, and the cyclin-dependent kinase (CDK) 4/6 inhibitor, G1T38, on tumor growth in an AR-V7+ castration-resistant prostate cancer (CRPC) xenograft model
Wardell, Suzanne E., Yllanes, Alexander P., Norris, John D., Stice, James P., White, Hannah, Fleming, Ronald A., Strum, Jay C., Moore, William R., McDonnell, Donald P.
Published in Cancer research (Chicago, Ill.) (01.07.2017)
Published in Cancer research (Chicago, Ill.) (01.07.2017)
Get full text
Journal Article